Zheling Chen
No 158 Shangtang Road
Hangzhou, 310000, China
Hangzhou, 310000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Risk-Stratified Management of ADC drug-Related Neutropenia: Integrating Clinical Trial Meta-Summary and Existing Guideline Principles.
Journal: Cancer research and treatment
Published: May 16, 2025
A novel oncolytic poxvirus carrying CD47 nanomabs in the treatment of pancreatic cancer by reshaping the immune microenvironment.
Journal: Cancer letters
Published: February 26, 2025
Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review.
Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review.
Journal: Frontiers in oncology
Published: March 03, 2024
Unraveling role of ubiquitination in drug resistance of gynecological cancer.
Journal: American journal of cancer research
Published: February 26, 2024
Targeted mechanical forces enhance the effects of tumor immunotherapy by regulating immune cells in the tumor microenvironment.
Journal: Cancer biology & medicine
Published: January 17, 2023
Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 10, 2021
Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma.
Journal: Frontiers in oncology
Published: September 06, 2021
Conversion therapy, palliative chemotherapy and surgery, which of these is the best treatment for locally advanced and advanced pancreatic cancer?
Journal: Anti-cancer drugs
Published: August 30, 2021
A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Journal: Frontiers in oncology
Published: April 08, 2021
A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment.
Journal: Frontiers in immunology
Published: April 06, 2021
Management and Thinking on the Treatment of Cancer Patients During the COVID-19.
Journal: Frontiers in molecular biosciences
Published: February 27, 2021
The Anti-PD-1/PD-L1 Immunotherapy for Gastric Esophageal Cancer: A Systematic Review and Meta-Analysis and Literature Review.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: February 23, 2021
Last Updated: 09/26/2026